INTRODUCTION
============

Understanding how the vertebrate nervous system develops from the embryonic ectoderm has been one of the most intensely investigated developmental processes. The process of "neural induction" was discovered by Hans Spemann and Hilde Mangold; when dorsal mesoderm was transplanted adjacent to ventral ectoderm that normally would give rise to skin instead it formed a neural tube ([@b72-molcell-37-10-705], reprinted 2001). This result was interpreted to mean that dorsal mesoderm releases a signaling factor that converts the adjacent ectoderm into neural tissue. While the identity of this signal was sought for decades, only in recent years have we come to appreciate the signaling and transcription factors that mediate neural induction and control neural differentiation. Recently it has been possible to place these factors in a gene regulatory network that controls the progression of cells from newly induced neural precursors, to proliferative, multipotent neural plate stem cells, to specified neural progenitors. These early steps of neural development are critical for producing a pool of multipotent cells that later give rise to the multitude of neurons and glia in the central nervous system that have diverse and distinct functions, and are selectively affected in a number of human neurodegenerative diseases.

Research to produce a population of cells *in vitro* that recapitulate the differentiated progeny seen in the intact nervous system has defined a "neural stem cell" (NSC), which is a self-renewing cell whose progeny can produce neurons, oligodendrocytes and astrocytes ([@b24-molcell-37-10-705]). In the embryonic neural tube these cells reside in the ventricular zone (or subventricular zone in the developing cerebral cortex), and in both the embryo and in NSC cultures, these cells are activated to produce new progeny by the integration of a number of signaling pathways, such as Sonic Hedgehog, BMP, Wnt/βCatenin, Notch, and FGF ([Fig. 1](#f1-molcell-37-10-705){ref-type="fig"}; [@b9-molcell-37-10-705]; [@b16-molcell-37-10-705]; [@b37-molcell-37-10-705]; [@b49-molcell-37-10-705]; [@b58-molcell-37-10-705]; [@b59-molcell-37-10-705]; [@b93-molcell-37-10-705]). In both the embryo and in NSC cultures, the self-renewal ability of these cells is regulated by numerous transcription factors, including Hes, Sox, Bmi1, Tlx, and Gli proteins ([Fig. 1](#f1-molcell-37-10-705){ref-type="fig"}; [@b1-molcell-37-10-705]; [@b11-molcell-37-10-705]; [@b15-molcell-37-10-705]; [@b23-molcell-37-10-705]; [@b25-molcell-37-10-705]; [@b32-molcell-37-10-705]; [@b35-molcell-37-10-705]; [@b46-molcell-37-10-705]; [@b50-molcell-37-10-705]; [@b59-molcell-37-10-705]; [@b77-molcell-37-10-705]; [@b87-molcell-37-10-705]). The recognition of this cell has inspired numerous researchers to develop new culturing approaches to obtain specific kinds of neurons or glia for therapeutic purposes, such as striatal neurons for Huntington's disease and dopamine neurons for Parkinson's disease. While there has been much success (e.g., reviewed in [@b13-molcell-37-10-705]; [@b64-molcell-37-10-705]), the potential presence of pluripotent stem cells in these cultures remains a concern because they might cause tumors if transplanted into patients.

Therefore, in this review we will focus on what we know about the functions of the signaling and transcriptional factors that control the earliest steps in neural development in the vertebrate embryo. These are the steps that control commitment to a neural fate, proliferation of immature cells, and initiation of differentiation. If we can determine whether the molecular interactions that occur in the embryo to regulate how cells initially become committed to a neural fate are similarly employed when embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are differentiated into NSCs, we will be able to eliminate tumorigenic cells. Therefore, we will relate the findings from embryos to studies of cultured mammalian stem cells in expectation that the knowledge gained from the embryo will significantly enhance *in vitro* stem cell approaches and thereby yield transplantable neural precursors for regenerative applications.

NEURAL INDUCTIVE SIGNALING
==========================

The vertebrate neural ectoderm forms on the dorsal side of the embryo in response to signals from the adjacent dorsal mesoderm, which is called the "Organizer" in frog and fish and the "Node" in chick and mouse (reviewed in [@b18-molcell-37-10-705]; [@b36-molcell-37-10-705]; [@b43-molcell-37-10-705]; [@b51-molcell-37-10-705]; [@b62-molcell-37-10-705]; [@b73-molcell-37-10-705]). Small diffusible proteins that are secreted from the Organizer bind to either BMP or Wnt ligands and prevent them from activating their receptors in the adjacent ectoderm. Embryonic ectodermal cells become epidermis (skin) in the presence of BMPs and Wnts and become neural ectodermal (NE) precursors in their absence ([Fig. 1](#f1-molcell-37-10-705){ref-type="fig"}). The newly induced NE precursors express a large number of neural transcription factors (nTFs), including members of the Fox, Sox, Zic and Irx families, that are co-expressed in broad overlapping domains. Some of these factors regulate the competence of the NE precursors to respond to neural inducing signals and cause the newly induced neural cells to become refractory to BMP and Wnt signals ([@b51-molcell-37-10-705]; [@b62-molcell-37-10-705]; [@b65-molcell-37-10-705]).

FGF signaling is another important pathway that facilitates neural induction ([Fig. 1](#f1-molcell-37-10-705){ref-type="fig"}; [@b74-molcell-37-10-705]; 2000; [@b86-molcell-37-10-705]). One of the downstream effectors of the FGF neural promoting activity is a protein called Churchill (Churc), which up-regulates early neural genes and down-regulates early mesodermal genes ([@b69-molcell-37-10-705]). Its activity is mediated, at least in part, by a Smad-interacting protein called Sip1 ([@b81-molcell-37-10-705]). Sip1 is expressed in the dorsal ectoderm at the time that neural induction is occurring, converts naïve ectoderm to neural ectoderm, represses mesoderm genes and inhibits BMP signaling ([@b20-molcell-37-10-705]; [@b56-molcell-37-10-705]; [@b57-molcell-37-10-705]). The FGF-mediated switch from mesodermal to neural fates also is regulated by a pluripotency transcription factor, POU91/Oct4, upstream of *Churc* and *Sip1*([@b70-molcell-37-10-705]). Thus, these factors appear to be activated at the time cells are switching off a pluripotency program.

Adding neural inducing factors to ESC or iPSC cultures also directs these cells to become NE precursors (also called primitive neural stem cells) ([@b19-molcell-37-10-705]; [@b79-molcell-37-10-705]). Some of the cells in ESC cultures secrete BMPs and Wnts, and maintaining NE precursors depends on inhibiting these signals ([@b79-molcell-37-10-705]), just as in the embryo. Maintaining the expression of *SOX1* in human ESC and iPSC cultures also requires continuous down-regulation of BMP signaling ([@b12-molcell-37-10-705]; [@b54-molcell-37-10-705]). However, unlike in the embryo, FGF signaling inhibits human ESCs from forming neural tissues, at least under some culture conditions ([@b31-molcell-37-10-705]). It is not clear whether this means that FGF signals have different effects in embryos versus ESCs, or whether FGF signaling acts to promote mesoderm formation under these culture conditions. It will be very informative to more precisely determine the roles of FGF signaling in neural induction of cultured stem cells. To our knowledge, no studies have been published regarding Churc function in stem cell cultures. But, SIP1 plays a key role in the decision between neural ectoderm and mesendoderm in human ESCs and in mouse epiblast stem cells ([@b14-molcell-37-10-705]). Thus, the evidence so far suggests that the induction of the NE precursor state in ESC and iPSC cultures relies upon some of the same signaling factors as in the embryo. Further study of the timing and effectiveness of these factors in both embryos and stem cell cultures may reveal how to drive cells towards a stabilized neural fate and prevent the formation of unwanted lineages.

Transitioning to neural plate stem and neural progenitor cells
--------------------------------------------------------------

Once the neural ectoderm is induced and the nTFs are expressed, the tissue continues to be exposed to both BMP and Wnt signals from the surrounding mesoderm and ectoderm. It has been proposed that some of the earliest expressed nTFs somehow stabilize the neural fate program, and thereby prevent cells from reverting to a non-neural fate ([@b65-molcell-37-10-705]). Since several of the nTF genes can be directly repressed by BMP-regulated transcription factors ([@b61-molcell-37-10-705]; [@b78-molcell-37-10-705]), stabilizing a cell's commitment to a neural fate is important as the signaling environment changes in the embryo. One such factor is Zic1, which causes the embryonic ectoderm to be more sensitive to neural inductive signals ([@b41-molcell-37-10-705]). To date, the mechanism by which this occurs has not been defined, but perhaps Zic1 attenuates some aspect of BMP or Wnt signaling. In fact, there is evidence for this for many of the other nTFs. Gmnn and Irx1/Xiro1 reduce *Bmp4* mRNA levels when ectopically expressed in epidermal domains ([@b26-molcell-37-10-705]; [@b29-molcell-37-10-705]; [@b40-molcell-37-10-705]). Sox3 down-regulates the expression of the BMP target, *Vent2*, which is required for epidermis formation ([@b61-molcell-37-10-705]; [@b63-molcell-37-10-705]). Foxd4 down-regulates the expression of several genes in the BMP pathway, including their epidermal gene targets, and also reduces the nuclear localization of the phosphorylated SMADs that are the effectors of BMP signaling ([@b88-molcell-37-10-705]; [@b89-molcell-37-10-705]). Sox11 interacts with the MAP kinase NLK to antagonize Wnt signaling by phosphorylating the TCF/βcatenin complex ([@b33-molcell-37-10-705]). Ectopic expression of *Foxd4* mRNA in the epidermal lineage, which is a field of high BMP/Wnt expression, induces several other nTFs in presumptive epidermal cells, indirectly indicating that the BMP and/or Wnt pathways have been repressed ([@b88-molcell-37-10-705]). In fact, we recently found that mouse Foxd4 has the same effects in *Xenopus* embryos, indicating conservation of this protein's function (unpublished).

These studies in embryos demonstrate that the combined anti-BMP and anti-Wnt activities of several of the earliest expressed nTFs maintain a permissive neural ectoderm environment by dampening the effects of inhibitory BMP and Wnt signals that persist in the embryo after neural induction. Maintenance of a BMP/Wnt-free environment effectively stabilizes the neural fate of the NE precursors, which allows them to transition into neural plate stem cells and prevents them from converting back to a non-neural state. To our knowledge, the roles of these early nTFs in stabilizing neural fates in mammalian ESC cultures have not been explored. We hypothesize that nTFs have a role because maintaining NE precursors depends on inhibiting BMP and Wnt signals ([@b79-molcell-37-10-705]), and maintaining the expression of *SOX1,* another nTF, in human ESC and iPSC cultures requires continuous down-regulation of BMP signaling ([@b12-molcell-37-10-705]; [@b54-molcell-37-10-705]). Thus, the maintenance of the NE precursor state in ESC and iPSC cultures may rely upon some of the same signaling and transcription factors as in the embryo.

Expansion of neural plate stem cells
------------------------------------

Once the neural ectoderm has been induced, the cells become highly proliferative and take on a columnar shape, thus forming the neural plate, a morphologically distinct domain that will give rise to the central nervous system. Numerous experiments in embryos show that when the level of each nTF is experimentally increased in NE precursors the neural plate is expanded. This phenotype may occur because the nTFs have broadened the domain in which BMP signaling is repressed, as described above. However, neural plate expansion also appears to result from the ability of some nTFs to promote the proliferation of neural plate stem cells, and/or delay their differentiation into neural progenitors. For example, in *Xenopus* embryos, Gmnn maintains NE precursors in a proliferative state by modulating interactions between the SWI/SNF complex and the bHLH transcription factors that promote neural differentiation ([@b67-molcell-37-10-705]; [@b68-molcell-37-10-705]). Foxd4 also increases the number of proliferating cells, expands markers of immature neural ectoderm, and down-regulates *bHLH* neural differentiation genes ([@b51-molcell-37-10-705]; [@b76-molcell-37-10-705]). Interestingly, *Gmnn* and *Foxd4* are down-regulated as neural plate stem cells exit the cell cycle and differentiate into neural progenitors ([@b40-molcell-37-10-705]; [@b76-molcell-37-10-705]), indicating that their activities must be suppressed for neural differentiation to proceed. Zic2 also represses *bHLH* neural differentiation genes and counteracts the formation of extra neurons when *bHLH* genes are ectopically expressed in the epidermis ([@b10-molcell-37-10-705]). These studies indicate that Gmnn, Foxd4 and Zic2 cause neural plate expansion by promoting NE precursor and neural stem cell proliferation and delaying the bHLH-mediated establishment of differentiating neural progenitors.

Other nTFs appear to promote the transition of neural plate stem cells to neural progenitor cells, a process that requires cells to exit the cell cycle and initiate *bHLH* neural differentiation gene expression ([@b34-molcell-37-10-705]). In several animals, SoxB1 family members (*Sox1*, *Sox2*, *Sox3*) maintain neural stem populations and must be down-regulated for neural progenitor differentiation to proceed ([@b11-molcell-37-10-705]; [@b38-molcell-37-10-705];[@b47-molcell-37-10-705]; [@b60-molcell-37-10-705]). When expressed at high levels, each maintains neural stem cells in a proliferative state upstream of neuronal differentiation genes ([@b4-molcell-37-10-705]; [@b21-molcell-37-10-705]; [@b30-molcell-37-10-705]; [@b44-molcell-37-10-705];[@b82-molcell-37-10-705]; [@b84-molcell-37-10-705]; [@b92-molcell-37-10-705]). Likewise, Sox11, a member of the SoxC subfamily, is up-regulated as neural stem cells transition to neural progenitor cells, and later maintains neuronal progenitors ([@b6-molcell-37-10-705]; [@b80-molcell-37-10-705];[@b84-molcell-37-10-705]). Thus, together these *Sox* genes may function downstream of Foxd4, Gmnn and Zic2 to promote the initial step from neural plate stem cell to neural progenitor cell.

Several studies show that other *Zic* genes and the *Irx* genes function in neural progenitors downstream of the *SoxB1* genes to promote the onset of *bHLH* neural differentiation gene expression. Zic1 is required for the expression of *SoxD* (a member of the SoxG group), which causes ectopic neural masses that express *bHLH* neural differentiation genes ([@b48-molcell-37-10-705]), and Zic1 and Zic3 promote the expansion of neural progenitors in the spinal cord and forebrain ([@b2-molcell-37-10-705]; [@b52-molcell-37-10-705]; [@b53-molcell-37-10-705]). In *Drosophila*, *Iroquois* genes are required for the activation of the proneural *bHLH* genes ([@b27-molcell-37-10-705]), and in *Xenopus* the homologous *Irx/Xiro* genes are expressed just prior to the earliest expressed *bHLH* neural differentiation genes([@b5-molcell-37-10-705]). While *Irx* genes promote the onset of neural differentiation ([@b5-molcell-37-10-705]; [@b28-molcell-37-10-705]), they also suppress terminal differentiation into neurons ([@b17-molcell-37-10-705]).

These studies demonstrate that the nTFs have important roles in maintaining a NE precursor state, regulating the size of the neural plate stem cell population and controlling the onset of differentiation of the neural progenitor cells. However, their functions in cultured stem cells has not been extensively explored. To date, most emphasis has been put on forcing stem cells to a neural fate and then differentiating them into specific neuronal and glial types ([@b13-molcell-37-10-705]; [@b64-molcell-37-10-705]; [@b85-molcell-37-10-705]). However, a common problem with these protocols is the difficulty in maintaining neural precursors in an immature, undifferentiated state. For many therapeutic applications this would be advantageous because it would expand neural precursor cells without the spontaneous and premature differentiation that commonly occurs in these cultures. In the embryo, proliferative NE precursors first form from embryonic ectoderm in response to neural inductive signaling. Next, as the neural plates forms, these cells transition into neural plate stem cells which subsequently differentiate into regionally-specified neural progenitor cells. Whereas in the embryo, proliferative, undifferentiated neural precursors can be maintained, it is rare to see this kind of cell in ESC cultures. However, similar primitive neural precursors do form in mouse ESC cultures when neural inductive signaling is maintained either by adding anti-BMP factors or growing cells at a low enough density to dilute endogenously produced BMPs ([@b79-molcell-37-10-705]). The molecular mechanisms by which this primitive state is acquired and maintained, and by which these cells transition to the better characterized neural stem cell state will be important to elucidate in light of the potential to eliminate tumor-producing pluripotent cells.

A neural plate gene regulatory network
--------------------------------------

The studies summarized above took a gene-by-gene approach to understand the functions of each nTF during the progressive transition from neural inductive signaling to neural progenitor differentiation. Based on their sequential and overlapping activities it seems likely that the nTFs coordinately function in a gene regulatory network ([Fig. 2](#f2-molcell-37-10-705){ref-type="fig"}). An initial set of nTFs maintains cells in a stable, immature NE precursor state that proliferates to form an appropriately sized neural plate. These are then down-regulated and a different set of nTFs is activated to promote the formation of the neural stem cell constituents of the neural plate. Finally, neural stem cell nTFs are down-regulated and a third set of nTFs is activated that initiate neural differentiation. Our understanding of the functional and transcriptional relationships between these proteins is woefully incomplete, yet this information is fundamental for understanding how the balance between neural precursor, neural stem and neural progenitors is molecularly regulated.

Developmental events often are controlled by regulatory networks of transcription factors that control temporal and region-specific gene expression ([@b42-molcell-37-10-705]). Therefore, we sought to place these nTFs in a network to determine their distinct roles in the progression from NE precursors to differentiating neural progenitors by analyzing the epistatic position of Foxd4 amongst these other nTFs. Using protein knock-down approaches we found that Foxd4 is required for the expression of each of the other nTFs([@b88-molcell-37-10-705]), thus placing it upstream in the network ([Fig. 2](#f2-molcell-37-10-705){ref-type="fig"}). Using gain-of-function approaches, we found that elevated FoxD4 levels in NE precursors up-regulated *Gmnn* and *Zic2*, delayed the expression of *Sox2*, *Sox3* and *Sox11*, which resulted in an expanded neural plate; and down-regulated the *Zic* and *Irx* genes that promote neural progenitor differentiation. We also found that *Foxd4* expression is down-regulated at early neural plate stages, suggesting that its repression is required for NE precursors to progress to neural plate stem cells and to neural progenitors. Additional experiments demonstrated that Gmnn, Zic2 and Sox11 together can mediate the Foxd4 effects on the remaining nTFs([@b88-molcell-37-10-705]). From these results we can construct a gene regulatory network in which Foxd4 is a critical upstream component. It directly activates a transcriptional triad consisting of *Gmnn*, *Zic2* and *Sox11*, which in turn regulates the more down-stream components that promote the transition to neural stem and neural progenitor cells ([Fig. 2](#f2-molcell-37-10-705){ref-type="fig"}). Finally, structure-function analyses of the Foxd4 protein show that it has separate domains in the N-and C-terminal regions that account for its ability to both activate or repress targets ([@b39-molcell-37-10-705]; [@b55-molcell-37-10-705]). These findings illustrate how a single transcription factor can regulate the transition of immature, NE precursors to neurally-committed stem cells, and then to neural progenitors that are beginning to differentiate.

The experiments described above demonstrate that Foxd4 is a critical element in the gene regulatory network that regulates the balance between NE precursors, neural plate stem cells and regionally specified neural progenitor cells. Elucidating how these different nTF genes interact to regulate this balance between expanding precursor populations and initiating differentiation should ultimately prove useful for preventing the formation of mesodermal and endodermal cells in neuronal culture protocols, expanding the number of neural precursors available and preventing their premature differentiation.

One would predict from the experiments performed in embryos that during the differentiation of ESCs into NSCs Foxd4, Gmnn, Zic2 and Sox11 would act early to promote immature, proliferative NE precursors and impede neural differentiation ([Fig. 2](#f2-molcell-37-10-705){ref-type="fig"}). Our preliminary work analyzing the role of Foxd4 in embryoid bodies derived from mouse ESCs and differentiated along a neural lineage indicates that this protein is key to the transition between pluripotency and neurally committed cells, just as in the embryo ([@b51-molcell-37-10-705], and unpublished observations). In the embryo, Gmnn promotes an uncommitted state by promoting Polycomb mediated repressive histone marks at differentiation-promoting genes ([@b45-molcell-37-10-705]). It also prevents premature neurogenesis by antagonizing the interaction between Brg and bHLH neural differentiation factors ([@b68-molcell-37-10-705]). Just like in the embryo, in mouse ESCs Gmnn is required for the acquisition of a neural fate, and can promote the formation of neural precursor cells by maintaining the chromatin in a hyper-acetylated state and in an open conformation that allows other nTFs access to their binding sites on the DNA ([@b90-molcell-37-10-705]). Subsequent work showed that Gmnn promotes both activating and repressive histone modifications at neural differentiation genes, suggesting that Gmnn makes the chromatin accessible to both factors that promote NE precursors as well as to factors that will subsequently activate neural differentiation genes ([@b91-molcell-37-10-705]). These results explain why Gmnn-deficient neural progenitors in the mouse cortex are defective in cell proliferation and differentiation ([@b71-molcell-37-10-705]), whereas Gmnn-deficient NSCs in neurospheres can still divide and differentiate into neurons and glia ([@b66-molcell-37-10-705]).

Whereas the role of Zic2 has not been examined in ESC culture, *Sox* genes have been extensively studied. SoxB1 family proteins (Sox1, Sox2, Sox3) are expressed throughout mouse and chick embryo NE precursors and neural plate stem cells, and when expressed at high levels they prevent cells from differentiating into neurons ([@b80-molcell-37-10-705]; [@b83-molcell-37-10-705]). In addition, Sox2 has an earlier function in ESCs: maintenance of pluripotency([@b3-molcell-37-10-705]). *Sox11* is expressed through-out NE precursors and neural plate stem cells, overlapping completely with *Sox2* and *Sox3* expression in *Xenopus* ([@b33-molcell-37-10-705]), whereas in chick and mouse embryos, it is expressed later in neural progenitors and differentiating neurons, and does not overlap with *Sox2* or *Sox3* expression in the neural tube ([@b80-molcell-37-10-705]; [@b83-molcell-37-10-705]); in mouse it also is expressed in several other tissues to support progenitor cell survival ([@b8-molcell-37-10-705]). A recent study showed that Sox2, Sox3 and Sox11 bind to the promoters/enhancers of the same neural genes expressed in mouse NSCs, neural progenitors and differentiating neurons in a defined temporal sequence ([@b7-molcell-37-10-705]). In ESCs, Sox2 binds to NSC genes to mark sites for later Sox3 binding. Subsequently in NSCs, Sox3 binds to neuronal differentiation genes to mark sites for later Sox11 binding. In each case, Sox protein binding results in biva-lent chromatin marks, indicating that part of their effect is making the appropriate neural genes accessible to other transcriptional factors that are expressed later.

Neural progenitor differentiation
---------------------------------

There is a large literature that describes the nTFs that are involved in neural progenitor cell (NPC) formation that has been extensively reviewed elsewhere ([@b22-molcell-37-10-705]; [@b34-molcell-37-10-705]). As mentioned above, the bHLH factors, particularly NeuroG and NeuroD are critical for NPCs to exit the cell cycle and activate neuron or glial specific genes. In addition, pattern formation genes are important in providing NPCs with their spatial address within the neural tube. Depending upon whether the NPC is located in the anterior or posterior, dorsal or ventral parts of the neural tube, the expression of patterning genes will impact whether it differentiates into the forebrain versus spinal cord, and sensory versus motor neuron.

CONCLUSION
==========

A large literature describes the signaling and transcriptional factors that are responsible for differentiating neural progenitor cells into the wide range of neurons and glia that are responsible for the complex function of the vertebrate central nervous system. These factors are important for understanding how the brain functions, and for designing stem cell protocols to replace specific cells affected by neurodegenerative disease and injury. In contrast, much less in know about the molecular regulation that guides a newly induced neural ectodermal cell to commit to its new fate, expand the neural plate stem cell population and transition to a neural progenitor cells. As work in the embryo reveals more details about the regulation of these earliest steps in neural development, we need to test these details in cultured stem cell paradigms to facilitate the manipulation of NSCs for therapeutic uses. It is now important to test these possibilities experimentally, and elucidate the essential gene regulatory network in mammalian ESC-and iPSC-derived neural cell cultures. Using the information we have obtained from the embryo should greatly facilitate these efforts.
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![A schematic representation of main signaling pathways involved in NTFs development during embryogenesis. Five major signaling pathways including SHH, BMP, WNT, Notch ligands and FGF2, together crosstalk is represented. SHH ligand relieves the constitutive repression of the seven-pass receptor smoothened (SMO) by the modulation of the GLI transcriptional activators Gli1/2. Extracellular regulation of BMP signaling BMP induces the dimerization and then tetramerization of BMP receptors, leading to phosphorylation of the cytoplasmic signal transducer SMAD. WNT signaling activates β-catenin by modulating Frizzed and Dsh. Transcription factor LEF is required for enhancing of E2F1, consequently block Bmi1. The Notch and FGF2 signaling pathways have been implicated in regulating the neural differentiation and development. Notch interacts with NICD and mediates the effect of Hes1 and Gli/12. FGF2 activates JNK through binding with FGFR receptors, thus activating ATF2 regulatory mechanisms in neural development.](molcell-37-10-705f1){#f1-molcell-37-10-705}

![A gene regulatory network of neural transcription factors that regulate the earliest steps in vertebrate neural development. Foxd4 is required for the expression of the remaining genes, and it directly activates Geminin, Zic2 and Sox11 (blue arrows). Together, these three genes mediate the downstream effects of Foxd4, which is to delay the expression of neural plate stem cell genes (Sox) and repress the expression of neural progenitor genes (Irx, Zic, bHLH).](molcell-37-10-705f2){#f2-molcell-37-10-705}
